Savant Fine-Chems Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 44.05%
- Profit Growth -214.16%
- Ebitda -214.16%
- Net Worth -159.40%
- Total Assets 72.97%
About Savant Fine-Chems
Savant Fine-Chems Private Limited (SFPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 March 2011 and has a history of 13 years and ten months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jyothi Kalepu, Venkateswara Yarlagadda, and Rajeswari Yarlagadda serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24100TG2011PTC073614
- Company No.
073614
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Mar 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Savant Fine-Chems?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jyothi Kalepu  | Director | 30-Mar-2011 | Current |
| Venkateswara Yarlagadda | Director | 30-Mar-2011 | Current |
| Rajeswari Yarlagadda | Director | 30-Mar-2011 | Current |
Financial Performance of Savant Fine-Chems.
Savant Fine-Chems Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 44.05% increase. The company also saw a substantial fall in profitability, with a 214.16% decrease in profit. The company's net worth observed a substantial decline by a decrease of 159.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Savant Fine-Chems?
In 2020, Savant Fine-Chems had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Savant Envitech Private LimitedJyothi Kalepu and Venkateswara Yarlagadda are mutual person
Savant Projects LlpJyothi Kalepu, Venkateswara Yarlagadda and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Savant Fine-Chems?
Unlock and access historical data on people associated with Savant Fine-Chems, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Savant Fine-Chems, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Savant Fine-Chems's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.